National Institute of Diabetes and Digestive and Kidney Disorders; Notice of Closed Meeting, 36092-36093 [E8-14278]

Download as PDF 36092 Federal Register / Vol. 73, No. 123 / Wednesday, June 25, 2008 / Notices mstockstill on PROD1PC66 with NOTICES property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institutes of Health, Room 2c212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7704, crucew@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Name of Committee: National Institute on Aging Special Emphasis Panel; Aging Auditory System. Date: July 16, 2008. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: William Cruce, PhD, Health Scientist Administrator, Scientific Review Office, National Institute on Aging, National Institutes of Health, Room 20212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7704, crucew@nia.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Aging Special Emphasis Panel; Proteinopathies in ALS-Dementia. Date: July 23, 2008. Time: 1:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: William Cruce, PhD, Health Scientist Administrator, Scientific Review Office, National Institute on Aging, National Institutes of Health, Room 2c212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7704, crucew@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; DNA Damage, Repair and Aging. Date: July 25, 2008. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20814, (Telephone Conference Call). Contact Person: Elaine Lewis, PhD, Scientific Review Administrator, Scientific Review Office, National Institute on Aging, Gateway Building, Suite 20212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7707, elainelewis@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; Aging and Senile Dementia. Date: August 7, 2008. Time: 1 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue 2c212, Bethesda, MD 20814, (Telephone Conference Call). Contact Person: William Cruce, PhD, Health Scientist Administrator, Scientific Review Office, National Institute on Aging, Dated: June 18, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14264 Filed 6–24–08; 8:45 am] VerDate Aug<31>2005 21:19 Jun 24, 2008 Jkt 214001 BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Proteomics Center for HIV/AIDS and Addiction. Date: July 21–22, 2008. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Mark Swieter, PhD, Chief, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 6101 Executive Boulevard, Suite 220, Bethesda, MD 20892–8401, (301) 435–1389, ms80x@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: June 18, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14277 Filed 6–24–08; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disorders; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2) notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for type 1 diabetes. The outcome of the evaluation will be a decision whether NIDDK should support the request and make available contract resources for development of the potential therapeutic to improve the treatment or prevent the development of type 1 diabetes and its complications. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Type 1 Diabetes— Rapid Access to Intervention Development Special Emphasis Panel; National Institute of Diabetes and Digestive and Kidney Diseases. Date: July 2, 2008. Time: 11 a.m.—12 p.m. Agenda: To evaluate requests for preclinical development resources for potential new therapeutics for type 1 diabetes and its complications. Place: 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dr. Myrlelne Staten, Senior Advisor, Diabetes, Translation Research, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, Bethesda, MD 20892–5460, 301 402–7886. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) E:\FR\FM\25JNN1.SGM 25JNN1 Federal Register / Vol. 73, No. 123 / Wednesday, June 25, 2008 / Notices Dated: June 18, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–14278 Filed 6–24–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2008–0061] Public Workshop: Implementing Privacy Protections in Government Data Mining Privacy Office, DHS. Notice announcing public workshop. AGENCY: mstockstill on PROD1PC66 with NOTICES ACTION: SUMMARY: The Department of Homeland Security Privacy Office will host a public workshop, Implementing Privacy Protections in Government Data Mining. DATES: The two-day workshop will be held on July 24, 2008, from 8:30 a.m. to 4:30 p.m., and on July 25th, 2008, from 8:30 a.m. to 12:30 p.m. Written comments should be received on or before July 17, 2008. ADDRESSES: The workshop will be held in the International Ballroom East, Hilton Washington, 1919 Connecticut Avenue, NW., Washington, DC 20009. Send comments by e-mail to privacyworkshop@dhs.gov, by fax to (703)–235–0442, or by mail to Toby Milgrom Levin, Senior Advisor, Privacy Office, Department of Homeland Security, Washington, DC 20528. All comments must include the words ‘‘Data Mining Workshop’’ and the Docket Number (DHS–2008–0061). To register for the Workshop, please send an e-mail to privacyworkshop@dhs.gov with ‘‘Data Mining Workshop Registration’’ in the subject line, and your name and organizational affiliation in the body of the e-mail. Alternatively, you may call 703–235–0780 to register and provide this information. FOR FURTHER INFORMATION CONTACT: Toby Milgrom Levin, DHS Privacy Office, Department of Homeland Security, Washington, DC 20528; by telephone 703–235–0780; by facsimile 703–235–0442; or by e-mail at privacyworkshop@dhs.gov. SUPPLEMENTARY INFORMATION: The Department of Homeland Security (DHS) Privacy Office is holding a public workshop to bring together leading academic, policy, and technology experts to explore methods of validating the accuracy and effectiveness of data mining models and rules, and the role VerDate Aug<31>2005 20:04 Jun 24, 2008 Jkt 214001 of anonymization tools and automated audit controls in protecting privacy. The purpose of the workshop is to inform the Privacy Office as it prepares its 2008 report to Congress on DHS data mining activities.1 The workshop will consist of a series of presentations and panel discussions that include the broad range of stakeholder perspectives. Workshop attendees will have an opportunity to ask questions after each panel. The workshop is open to the public, and no fee is required for attendance. Topics for Comment: To develop a comprehensive record regarding privacy protections in government data mining, the DHS Privacy Office also invites interested parties to submit written comments as described below. Comments should be received on or before July 17, 2008, and should be as specific as possible. The Privacy Office is particularly interested in receiving comments on the following topics: 1. How can government data mining activities be carried out in a manner that respects privacy? 2. How do the privacy issues posed by government data mining compare to those posed by other types of data analysis by the government? What are the similarities and differences? Are there privacy issues that are unique to government data mining? 3. What should be the elements of privacy best practices for government data mining? The Privacy Office requests that, where possible, comments include references to literature, technical standards and/or other resources that would support implementation of the best practices identified. 4. What should be the criteria for validating government data mining models and rules? 5. Are anonymization techniques or tools currently available that could be used in conjunction with government data mining? How effective are these techniques or tools? What are their costs and benefits? What degree of deidentification do they make possible? 6. What automated audit controls can be implemented in connection with 1 The Department has submitted three prior reports to the Congress on data mining: The 2008 Letter Report Pursuant to Section 804 of the Implementing Recommendations of the 9/11 Commission Act of 2007; the 2007 Data Mining Report: DHS Privacy Office Response to House Report 109–699 (July 6, 2007) and the Data Mining Report: DHS Privacy Office Response to House Report 108–774 (July 6, 2006). These reports are available on the DHS Privacy Office Web site at https://www.dhs.gov/privacy. The 2008 Letter Report provided a preliminary analysis of DHS data mining activities, with the understanding that a comprehensive report would follow. This workshop is intended to provide context for that comprehensive report. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 36093 government data mining? How effective are these controls? What are their costs and benefits? 7. Are there protections other than anonymization and automated audit controls that should be considered in connection with government data mining? How effective are any such protections? What are their costs and benefits? 8. Data quality plays an important role in the ability of government data mining techniques to produce accurate results. What data quality standards should DHS adopt for data mining? 9. What redress mechanisms should be implemented to protect privacy and also preserve the integrity and confidentiality of government investigative activities? Written comments must include the words ‘‘Data Mining Workshop’’ and the Docket Number (DHS–2008–0061), and may be submitted by any one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • E-mail: privacyworkshop@dhs.gov. Include ‘‘Data Mining Workshop Comment’’ in the subject line of the message. • Fax: 703–235–0442. • Mail: Toby Milgrom Levin, Senior Advisor, Privacy Office, Department of Homeland Security, Washington, DC 20528. All written comments received will be posted without alteration on the https://www.dhs.gov/privacy Web page for this workshop, including any personal contact information provided. Registration: In order to assist us in planning for the workshop, we ask that attendees register in advance. To register, please send an e-mail to privacyworkshop@dhs.gov with ‘‘Data Mining Workshop Registration’’ in the subject line, and your name and organizational affiliation in the body of the e-mail. Alternatively, you may call 703–235–0780 to register and to provide the DHS Privacy Office with your name and organizational affiliation, if any. The Privacy Office will use this information only for purposes of planning this workshop and to contact you in the event of any logistical changes. An agenda and logistical information will be posted on the workshop Web page shortly before the event. A written transcript will be posted on the Web page following the event. Special Assistance: Persons with disabilities who require special assistance should indicate this in their registration request and are encouraged E:\FR\FM\25JNN1.SGM 25JNN1

Agencies

[Federal Register Volume 73, Number 123 (Wednesday, June 25, 2008)]
[Notices]
[Pages 36092-36093]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14278]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney 
Disorders; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources for potential new therapeutics 
for type 1 diabetes. The outcome of the evaluation will be a decision 
whether NIDDK should support the request and make available contract 
resources for development of the potential therapeutic to improve the 
treatment or prevent the development of type 1 diabetes and its 
complications. The research proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the proposed research projects, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Type 1 Diabetes--Rapid Access to Intervention 
Development Special Emphasis Panel; National Institute of Diabetes 
and Digestive and Kidney Diseases.
    Date: July 2, 2008.
    Time: 11 a.m.--12 p.m.
    Agenda: To evaluate requests for preclinical development 
resources for potential new therapeutics for type 1 diabetes and its 
complications.
    Place: 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone 
Conference Call).
    Contact Person: Dr. Myrlelne Staten, Senior Advisor, Diabetes, 
Translation Research, Division of Diabetes, Endocrinology and 
Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, Bethesda, 
MD 20892-5460, 301 402-7886.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 36093]]


    Dated: June 18, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-14278 Filed 6-24-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.